TAKE Ltd

TAKE Other Announcement

Take Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).

TAKE Other Announcement

Take Limited has appointed M/s. Tejas Nadkarni & Associates as Internal Auditor. The appointment is effective for a 12-month term.

TAKE Other Announcement

Take Solutions Limited is changing its corporate name to TAKE Limited, effective August 12, 2026.

TAKE Other Announcement

Take Solutions Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. This is a routine regulatory disclosure under SEBI LODR regulations.

TAKE Other Announcement

Take Solutions Limited has changed its name to Take Limited. The company received the new Certificate of Incorporation on June 25, 2026.

TAKE Other Announcement

TAKE Solutions Limited appointed M/s. Hemang Satra & Associates as Secretarial Auditor for a five-year term. This follows the resignation of Mr. Ashok Ajay Kumar Bantia.

Execution

60 months

TAKE Other Announcement

Take Solutions announced its strategic entry into India's longevity and anti-ageing market. The company plans to develop science-backed nutraceuticals, biohacking solutions, and digital tools for preventive healthcare. This initiative leverages Take's expertise in clinical research and life sciences to target the rapidly growing USD 67 billion global longevity market projected by 2035.

TAKE Other Announcement

Take Solutions has launched a Rs. 5 Crore Innovation Fund to invest in AI, deep tech, and digital health startups. The fund targets the $400–500 billion Indian healthcare market, focusing on scalable technology and diagnostics. This initiative aligns with the company's strategic pivot toward high-margin, innovation-led sectors to drive long-term shareholder value.

Value

₹5.00 Cr